Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection

    Not yet recruiting

    3 1 1 1
    Sweden
  • Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

    Not yet recruiting

    2 1
    Investigated drugs:
    Czechia Germany Hungary Poland Spain
  • Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Germany Italy
  • Study of perineural incobotulinumtoxinA treatment for patients with Complex Regional Pain Syndrome type I or II affecting one side of the body

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Denmark
  • Study of dronabinol and cannabidiol oral solution for symptom relief in advanced cancer patients receiving opioid treatment

    Not yet recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study of tucatinib and trastuzumab for patients with HER3-mutant and HER2-not amplified metastatic breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Cannabidiol and Nutritional Supplements to Improve Muscle Health in Adults with Head and Neck Cancer Before Surgery

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • A Study of Oxytocin Nasal Spray to Reduce Psychological Stress in Women Who Have Recovered from Breast Cancer

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

    Not yet recruiting

    2 1 1 1
    Austria Belgium Denmark France Germany Italy +3
  • Study of TdT-3 cell therapy safety in patients aged 1 year and older with relapsed or refractory acute leukemia or lymphoblastic lymphoma

    Not yet recruiting

    2 1 1
    Norway